Drawing for CONCENTRIC CHEMISTS

USPTO serial 98941837

CONCENTRIC CHEMISTS

Reviewed by CopyMark Law Group

Status 730Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
HOFFMAN, CHRISTOPHER J
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 730: Status 730 means you filed the first six-month extension to delay filing a Statement of Use after a Notice of Allowance. You must file a Statement of Use or another extension before the new deadline.

Need help with CONCENTRIC CHEMISTS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*

Plus Government fees of $450

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated cleansers for personal use, namely, skin cleansers, facial cleansers, body cleansers; moisturizing creams; non-medicated skin serums; non-medicated skin toners; non-medicated skin care preparations; pre-moistened cosmetic wipes; wipes impregnated with a skin cleanser; exfoliant creams; exfoliant gels; brightening face cream; brightening eye cream; age spot reducing cream; anti-aging creams; anti-aging toner; anti-aging cleanser; skin masks; body masks; beauty masks; facial sheet masks for cosmetic use; sheet masks for the neck for cosmetic use; sheet masks for the body for cosmetic use; facial patches being non-medicated skin care preparations for cosmetic use; gel eye patches for cosmetic purposes; cosmetic patches containing sunscreen and sun block for use on the skin; skin cream; skin and body topical lotions, creams and oils for cosmetic use; face oils; hand creams; eye cream; neck creams being non-medicated skin care preparations; sunscreen; tanning and after-sun milks, gels, and oils; skin gels for accelerating, enhancing or extending tans; sun-tanning preparations; cosmetic tanning preparations; self-tanning preparations; cosmetic preparations for the bath and shower; cuticle cream; cuticle oil; non medicated nail care preparations; non-medicated lip care preparations; hair care preparations; cosmetic preparations for the hair and scalp; non-medicated preparations all for the care of skin, hair and scalp; hair styling preparations; non-medicated hair treatment preparations for cosmetic purposes; leave-in hair conditioners; non-medicated skin cream for general skin rash and irritation resulting from skin shingles; wrinkle-minimizing cosmetic preparations for topical cosmetic useACTIVE—
005Dietary supplements; dietary supplemental drinks in the nature of vitamin and mineral beverages; gummy vitamins being dietary supplements; vitamin and mineral supplements being dietary supplements; medicated skin care preparations, namely, creams, serums, lotions, gels, toners, cleaners and peels; antimicrobials for dermatologic use; antifungal preparations; antibacterial substances for medical purposes; tissues impregnated with antibacterial preparations; antibacterial wipes; antibacterial pharmaceuticals; antibacterial spray; antibiotic preparations; antivirals; cold sore treatment preparations; medicated sunscreen; medicated moisturizers; medicated pre-moistened tissues; medicated dermatological preparations and substances; medicated creams for treating dermatological conditions; medicated lotions for treating dermatological conditions; medicated ointments for treating dermatological conditions; medicated soaps; medicated shampoos; medicated dry shampoos; medicated dandruff shampoo; medicated bath soaps in liquid, solid or gel form; medicated facial cleansers; medicated skin care preparations, namely, pre moistened medicated wipes; medicated sunburn lotions; medicated skin care preparations, namely, pre-moistened medicated towelettes; medicated skin care preparations, namely, pre-moistened medicated tissues; bandages for dressings for skin wounds; adhesive bandages; antiseptic liquid bandages; liquid bandage sprays for skin wounds; gel wound dressings being bandages for skin wounds; pharmaceutical preparations for wounds, namely, antimicrobials for treating wounds; liquid bandages for skin wounds; wound dressings being bandages for skin wounds; medicated topical skin care preparations; medicated adhesive bands for medical purposes and medicated adhesive bandages; wound cleaning preparations, namely, medical cleansers wounds; first aid kits; plastic facial adhesive film for temporary wrinkle removal or reduction; transdermal patches being medicated skin care preparations for use in the treatment of dermatological conditions; multipurpose medicated antibiotic cream, analgesic balm and mentholated salve; medicated gels, creams and solutions for dermatological use; dermatological preparations, namely, medicated skin care preparations; parapharmaceutical products for use in treating psoriasis; medicated topical preparations, namely, ampoules sold filled with medicated serums for treatment of dermatological conditions; medicated skin irritation preparations, namely, non-medicated topical gel for the prevention and treatment of allergies; acne medications; medicated acne treatment preparations; patches impregnated with medicated acne treatment preparations; medical grade face masks, namely, medicated facial sheet masks; anti-inflammatory salves; anti-inflammatories; analgesic and anti-inflammatory preparations; medicated powder for skin treatment; medicated lip care preparations; medicated foot treatments, namely, medicated foot powder, lotion, cream, and bath preparations; medicated scalp treatment preparations, namely oil, cream, liquid serum; hair growth stimulants; medicated scalp treatment preparations in the nature of medicated anti-dandruff preparations, namely, shampoo, oil, serum, liquid; pharmaceutical preparations for treating dandruff; pharmaceutical preparations, namely, antivirals; antimicrobials for dermatologic use; pharmaceutical preparations, namely, an analgesic for human consumption taken orally; topical analgesic creams; pharmaceutical preparations in the nature of eye drops for the treatment of eye diseases and conditionsACTIVE—
010Electrically-powered apparatus for treating skin by applying low level light and sonic vibrations to the skin; dermarollers for medical use, namely, microneedle dermal roller; electronic light therapy apparatus for the skin; cosmetic apparatus using ultrasound for performing aesthetic skin treatment procedures; light emitting devices, namely, lamps and LED devices for treatment of a variety of skin conditions; phototherapeutic apparatus for medical purposes, namely, a LED (light-emitting diode) light source for medical and aesthetic skin treatments; lasers for the cosmetic treatment of the face and skin; cosmetic apparatus, namely, light-based devices providing mainly pulsed light for performing non-ablative aesthetic skin treatment procedures; lasers for skin treatment; dermarollers for medical use, namely, microneedle dermal pens; magnetic field generators for medical use; medical ultrasound apparatus for therapeutic purposes; cryotherapy machines for medical purposes; electronic aesthetic skin treatment devices using light emitting diodes, namely, infrared, red, orange, yellow, green, and blue wavelengths for generating light rays; facial and scalp massage apparatusACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 14, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 13, 2026EX1GSOU EXTENSION 1 GRANTED—
Apr 13, 2026EXT1SOU EXTENSION 1 FILED—
Apr 13, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 2, 2025NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 7, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 7, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 1, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 8, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 8, 2025XAECEXAMINER'S AMENDMENT ENTERED—
Sep 8, 2025GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 8, 2025GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 8, 2025CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 20, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 20, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 20, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 8, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 8, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 17, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 17, 2025DOCKASSIGNED TO EXAMINER—
Jan 7, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 7, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance